source
- STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricingThe pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.STAT · 2mo ago↗ source
- STAT+: A new attack on AMA’s billing codesA key GOP lawmaker is broadening the party's efforts to combat health care fraud.STAT · 2mo ago↗ source
- Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer CongressExperts in a range of breast cancer subtypes highlight research data being presented at the 2026 ESMO Breast Cancer Congress.onclive · 2mo ago↗ source